Search research articles
Contact Us
Filters
Showing results (31-40 of 74) with videos related to
Page
of 8
Sort By:
Biology
|
November 24, 2023
Novel Covalent Modifier-Induced Local Conformational Changes within the Intrinsically Disordered Region of the Androgen Receptor
Michael T Harnish, Daniel Lopez, Corbin T Morrison, et al.
Molecular Endocrinology (Baltimore, Md.)
|
September 20, 2008
Steroidal androgens and nonsteroidal, tissue-selective androgen receptor modulator, S-22, regulate androgen receptor function through distinct genomic and nongenomic signaling pathways
Ramesh Narayanan, Christopher C Coss, Muralimohan Yepuru, et al.
Bioorganic Chemistry
|
December 25, 2025
New Insights of Muraymycin A1 and Its Analogs as DPAGT1 Inhibitors
Katsuhiko Mitachi, Deidre Daria, Jacob M Kirsh, et al.
Bone
|
June 23, 2004
Differential skeletal responses of hindlimb unloaded rats on a vitamin D-deficient diet to 1,25-dihydroxyvitamin D3 and its analog, seocalcitol (EB1089)
Ramesh Narayanan, Matthew R Allen, Dana Gaddy, et al.
International Journal of Molecular Sciences
|
March 6, 2021
An Overview of Next-Generation Androgen Receptor-Targeted Therapeutics in Development for the Treatment of Prostate Cancer
Michael L Mohler, Arunima Sikdar, Suriyan Ponnusamy, et al.
Journal of Medicinal Chemistry
|
October 23, 2020
Pyrazol-1-yl-propanamides as SARD and Pan-Antagonists for the Treatment of Enzalutamide-Resistant Prostate Cancer
Yali He, Dong-Jin Hwang, Suriyan Ponnusamy, et al.
Journal of Medicinal Chemistry
|
July 16, 2021
Exploration and Biological Evaluation of Basic Heteromonocyclic Propanamide Derivatives as SARDs for the Treatment of Enzalutamide-Resistant Prostate Cancer
Yali He, Dong-Jin Hwang, Suriyan Ponnusamy, et al.
Journal of Medicinal Chemistry
|
February 24, 2023
Metabolism-Guided Selective Androgen Receptor Antagonists: Design, Synthesis, and Biological Evaluation for Activity against Enzalutamide-Resistant Prostate Cancer
Dong-Jin Hwang, Yali He, Suriyan Ponnusamy, et al.
Plos One
|
July 30, 2014
Selective androgen receptor modulators (SARMs) negatively regulate triple-negative breast cancer growth and epithelial:mesenchymal stem cell signaling
Ramesh Narayanan, Sunjoo Ahn, Misty D Cheney, et al.
Endocrinology
|
March 30, 2026
Role of JAK-STAT Signaling Pathway in Hormonal Cancer Therapeutic Resistance and Lineage Plasticity
Wendy Effah, Marjana Khalil, Sanskrita Sukla, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 74) with videos related to
Sort By:
Page
of 8
Biology
|
November 24, 2023
Novel Covalent Modifier-Induced Local Conformational Changes within the Intrinsically Disordered Region of the Androgen Receptor
Michael T Harnish, Daniel Lopez, Corbin T Morrison, et al.
Molecular Endocrinology (Baltimore, Md.)
|
September 20, 2008
Steroidal androgens and nonsteroidal, tissue-selective androgen receptor modulator, S-22, regulate androgen receptor function through distinct genomic and nongenomic signaling pathways
Ramesh Narayanan, Christopher C Coss, Muralimohan Yepuru, et al.
Bioorganic Chemistry
|
December 25, 2025
New Insights of Muraymycin A1 and Its Analogs as DPAGT1 Inhibitors
Katsuhiko Mitachi, Deidre Daria, Jacob M Kirsh, et al.
Bone
|
June 23, 2004
Differential skeletal responses of hindlimb unloaded rats on a vitamin D-deficient diet to 1,25-dihydroxyvitamin D3 and its analog, seocalcitol (EB1089)
Ramesh Narayanan, Matthew R Allen, Dana Gaddy, et al.
International Journal of Molecular Sciences
|
March 6, 2021
An Overview of Next-Generation Androgen Receptor-Targeted Therapeutics in Development for the Treatment of Prostate Cancer
Michael L Mohler, Arunima Sikdar, Suriyan Ponnusamy, et al.
Journal of Medicinal Chemistry
|
October 23, 2020
Pyrazol-1-yl-propanamides as SARD and Pan-Antagonists for the Treatment of Enzalutamide-Resistant Prostate Cancer
Yali He, Dong-Jin Hwang, Suriyan Ponnusamy, et al.
Journal of Medicinal Chemistry
|
July 16, 2021
Exploration and Biological Evaluation of Basic Heteromonocyclic Propanamide Derivatives as SARDs for the Treatment of Enzalutamide-Resistant Prostate Cancer
Yali He, Dong-Jin Hwang, Suriyan Ponnusamy, et al.
Journal of Medicinal Chemistry
|
February 24, 2023
Metabolism-Guided Selective Androgen Receptor Antagonists: Design, Synthesis, and Biological Evaluation for Activity against Enzalutamide-Resistant Prostate Cancer
Dong-Jin Hwang, Yali He, Suriyan Ponnusamy, et al.
Plos One
|
July 30, 2014
Selective androgen receptor modulators (SARMs) negatively regulate triple-negative breast cancer growth and epithelial:mesenchymal stem cell signaling
Ramesh Narayanan, Sunjoo Ahn, Misty D Cheney, et al.
Endocrinology
|
March 30, 2026
Role of JAK-STAT Signaling Pathway in Hormonal Cancer Therapeutic Resistance and Lineage Plasticity
Wendy Effah, Marjana Khalil, Sanskrita Sukla, et al.
Page
of 8